Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 976 AL 990

Growth Factor Gene Therapy for Alzheimer's Disease

Tuszynski MH.

J Alzheimers Dis. 2024;101(s1):S433-S441. doi: 10.3233/JAD-240545.

Oxidative Stress in Alzheimer's Disease: The Shortcomings of Antioxidant Therapies

Pappolla MA, Martins RN, Poeggeler B, Omar RA, Perry G.

J Alzheimers Dis. 2024;101(s1):S155-S178. doi: 10.3233/JAD-240659.

Hormone Replacement Therapy and Alzheimer's Disease: Current State of Knowledge and Implications for Clinical Use

Sayfullaeva J, McLoughlin J, Kwakowsky A.

J Alzheimers Dis. 2024;101(s1):S235-S261. doi: 10.3233/JAD-240899.

A systematic review of the efficacy and safety of anti-amyloid beta monoclonal antibodies in treatment of Alzheimer's disease

Chhabra A, Solanki S, Saravanabawan P, Venkiteswaran A, Nimmathota N, Modi NM.

Expert Opin Biol Ther. 2024 Nov;24(11):1261-1269. doi: 10.1080/14712598.2024.2416947. Epub 2024 Nov 12.

Surface engineered nano architectonics: An evolving paradigm for tackling Alzheimer's disease

Negi M, Amulya E, Phatale V, Abraham N, Hedaoo A, Srinivasarao DA, Srivastava S.

Life Sci. 2024 Dec 1;358:123155. doi: 10.1016/j.lfs.2024.123155. Epub 2024 Oct 19.

Gut microbiome-derived metabolites in Alzheimer's disease: Regulation of immunity and potential for therapeutics

Chandra S, Vassar RJ.

Immunol Rev. 2024 Oct;327(1):33-42. doi: 10.1111/imr.13412. Epub 2024 Oct 23.

Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease

Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H, Tassi I, Ward M, Yeh F, Schwabe T, Paul R, Kenkare-Mitra S, Rosenthal A.

Alzheimers Res Ther. 2024 Oct 23;16(1):235. doi: 10.1186/s13195-024-01599-1.

Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention

Gonçalves M, Costa M, Paiva-Martins F, Silva P.

Molecules. 2024 Oct 12;29(20):4841. doi: 10.3390/molecules29204841.

Role of Apolipoprotein E in Alzheimer's Disease Pathogenesis, Prognosis and Treatment

Reiss AB, Housny M, Gulkarov S, Hossain T, Locke B, Srivastava A, Pinkhasov A, Gomolin IH, Wisniewski T, De Leon J.

Discov Med. 2024 Oct;36(189):1917-1932. doi: 10.24976/Discov.Med.202436189.179.

Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels

Gonzalo R, Minguet C, Ortiz AM, Bravo MI, López OL, Boada M, Ruiz A, Costa M.

Ann Clin Transl Neurol. 2024 Dec;11(12):3280-3291. doi: 10.1002/acn3.52235. Epub 2024 Oct 30.

Indole-based COX-2 inhibitors: A decade of advances in inflammation, cancer, and Alzheimer's therapy

Shah M, Parmar R, Patel K, Nagani A.

Bioorg Chem. 2024 Dec;153:107931. doi: 10.1016/j.bioorg.2024.107931. Epub 2024 Oct 29.

Assessing the Role of the Generative Pretrained Transformer (GPT) in Alzheimer's Disease Management: Comparative Study of Neurologist- and Artificial Intelligence-Generated Responses

Zeng J, Zou X, Li S, Tang Y, Teng S, Li H, Wang C, Wu Y, Zhang L, Zhong Y, Liu J, Liu S.

J Med Internet Res. 2024 Oct 31;26:e51095. doi: 10.2196/51095.

Lifestyle empowerment for Alzheimer's prevention prescribed by physicians: Methods and adaptations to COVID-19

Szabo-Reed AN, Watts A, Vidoni ED, Mahnken J, Van Sciver A, Finley K, Clutton J, Holden R, Key MN, Burns JM.

Contemp Clin Trials. 2024 Dec;147:107729. doi: 10.1016/j.cct.2024.107729. Epub 2024 Nov 2.

A Comprehensive Analysis on Galantamine Based Hybrids for the Management of Alzheimer's Disease

Singh YP, Prasad S, Kumar H.

Chem Biol Drug Des. 2024 Oct;104(5):e70004. doi: 10.1111/cbdd.70004.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias